A new study to test the efficacy of Endocare C Proteoglycans Oil-Free vials of Cantabria Labs
A new study published on January 16 in the Journal of Clinical and Cosmetic Dermatology (M Vitale et al, 2018)...
Cantabria Labs, the natural evolution of IFC
As of today, Cantabria Labs is the new corporate brand name which will represent IFC, Industrial Farmaceutica Cantabria. It symbolises...
IFC awards pioneering research in the diagnosis of Multiple Sclerosis at the “IDEA² Global Awards” of MIT
Within the framework of the 2nd edition of the “IDEA2 Global Awards” given by the prestigious Massachusetts Institute of Technology...
The planting of two trees marks the start of construction of the new Industrial Farmacéutica Cantabria centre
Industrial Farmacéutica Cantabria (IFC) starts construction in La Concha, in the municipal area of Villaescusa (Cantabria), of its new centre...
Industrial Farmacéutica Cantabria opens a new subsidiary in China
Within the framework of its sustained, entrepreneurial, internationalisation process, Industrial Farmacéutica Cantabria (IFC) is set to arrive in China after...
IFC to promote and sponsor MIT programmes in biomedical innovation
Industrial Farmacéutica Cantabria and the Massachusetts Institute of Technology (MIT) have signed an agreement through which the laboratory will promote and sponsor...
New scientific endorsement for IFC®CAF, technology based on mollusk eggs rich in growth factors
A new article in the prestigious “American Journal of Drugs in Dermatology” highlights the efficacy of IFC®CAF technology, developed and...
IFC achieves a turnover of 126 million euros in 2016
Sales of IFC Group in 2016 topped 126 million euros, with over 20% growth on the previous year, highlighting the...
IFC opens a new subsidiary in Mexico to boost its international expansion
IFC – Industrial Farmacéutica Cantabria – takes on a new challenge with the opening of a subsidiary in Mexico as...
